Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
ling-gwuh ni-gō-tē: the language of business


Rome and Holmer present “Starting Your Life Sciences Company”

Peter Rome and Evelyn Holmer presented "Starting Your Life Sciences Company," an in-depth look at every step of the life sciences life cycle, from entity formation to exit strategy.

Tucker Ellis welcomes partner Peter Rome to Business Department

Tucker Ellis LLP is pleased to announce that Peter Rome has joined the firm’s Business Department as a member of its Corporate/M&A/Securities practice group.

Jayne Juvan comments to Law360 on private equity “health care craze”

On November 7, Jayne Juvan provided commentary to Law360 in "How Attys Can Capitalize on PE's Health Care Craze." The article focuses on the increasing activity of private equity firms in acquiring healthcare companies, even in light of a potential recession.

Diabetic Care RX case is a warning sign for private equity

The United States government recently sent shock waves through the private equity industry by charging a private equity firm for its portfolio company’s alleged health care fraud. The case, United States ex rel. Medrano v. Diabetic Care RX LLC d/b/a Patient Care America, involves alleged illegal conduct involved with pharmacy…

Juvan and Novak publish 2018 healthcare compliance outlook for boards of directors

In their article published by the Cleveland Metropolitan Bar Journal, Jayne Juvan and Kelli Novak examine the fiduciary duties applicable to boards of directors of health care organizations and examine key health care regulatory risk areas that boards should be aware of in 2018.